Meet us at ISN-WCN 2024 in Buenos Aires, 13–16 April!
TauroLock™ solutions meet the needs of patients suffering from kidney failure.
TauroLock™ solutions protect patients with central-venous catheters during cancer treatments.
TauroLock™ solutions facilitate parenteral nutrition for patients at all ages.
TauroLock™ is suitable for instillation in all central-venous access systems. It prevents the formation of bacterial biofilms and improves the patency rate.
TauroLock™-HEP100 can be used for patients who previously relied on heparin-based lock solutions. Central-venous catheters remain infection-free and sustain a high patency rate.
TauroLock™-HEP500 meets the particular needs of dialysis patients. It ensures a good flow-rate and prevents catheter-related infections as well as occlusions.
TauroLock™-U25.000 provides a strong protection against catheter-related complications. It contains taurolidine, 4 % citrate, and 25,000 IU of urokinase.
NutriLock™ is a heparin- and citrate-free lock solution. Based on the antimicrobial agent taurolidine, it protects patients against catheter-related infections.
Log in or sign up to download all available materials for free
Download a selected range of materials for free
How do lock solutions work and why is it so important to choose the right one?
TauroLock™ has proven effective against a wide range of bacteria and fungi (including MRSA and VRE).
Thanks to the active ingredient taurolidine, TauroLock™ lock solutions prevent the formation of biofilm.
The active ingredient citrate is an anticoagulant that prevents occlusions and maintains a high flow rate.
Answers to frequently asked questions about our products and safety guidelines.
We'll keep you posted on upcoming events, free download materials, and research insights.